资产负债表（Lineage Cell Therapeutics Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | ||||||||
| 现金及现金等价物(元) | 35,442,000.00 | 31,474,000.00 | 33,886,000.00 | 15,451,000.00 | 11,355,000.00 | 24,752,000.00 | 70,857,000.00 | 78,062,000.00 |
| 应收账款及票据(元) | 745,000.00 | 432,000.00 | 443,000.00 | 203,000.00 | 297,000.00 | 434,000.00 | 707,000.00 | 515,000.00 |
| 预付款项及其他应收款流动(元) | 2,204,000.00 | 1,717,000.00 | 2,123,000.00 | 2,638,000.00 | 1,828,000.00 | 1,720,000.00 | 1,289,000.00 | 1,413,000.00 |
| 短期投资(元) | 50,000.00 | 9,858,000.00 | 12,039,000.00 | 31,363,000.00 | 46,520,000.00 | 41,603,000.00 | 1,173,000.00 | 1,882,000.00 |
| 流动资产合计(元) | 38,441,000.00 | 43,481,000.00 | 48,491,000.00 | 49,655,000.00 | 60,000,000.00 | 68,509,000.00 | 74,026,000.00 | 81,872,000.00 |
| 非流动资产： | ||||||||
| 物业、厂房及设备(元) | 4,767,000.00 | 4,854,000.00 | 5,310,000.00 | 5,584,000.00 | 5,673,000.00 | 4,652,000.00 | 3,869,000.00 | 4,548,000.00 |
| 受限制存款及现金非流动(元) | 577,000.00 | 552,000.00 | 588,000.00 | 635,000.00 | 627,000.00 | 591,000.00 | 598,000.00 | 639,000.00 |
| 无形资产(元) | 46,562,000.00 | 46,594,000.00 | 46,627,000.00 | 46,659,000.00 | 46,692,000.00 | 46,724,000.00 | 46,757,000.00 | 46,789,000.00 |
| 商誉(元) | 10,672,000.00 | 10,672,000.00 | 10,672,000.00 | 10,672,000.00 | 10,672,000.00 | 10,672,000.00 | 10,672,000.00 | 10,672,000.00 |
| 非流动资产合计(元) | 62,578,000.00 | 62,672,000.00 | 63,197,000.00 | 63,550,000.00 | 63,664,000.00 | 62,639,000.00 | 61,896,000.00 | 62,648,000.00 |
| 总资产(元) | 101,019,000.00 | 106,153,000.00 | 111,688,000.00 | 113,205,000.00 | 123,664,000.00 | 131,148,000.00 | 135,922,000.00 | 144,520,000.00 |
| 流动负债： | ||||||||
| 融资租赁负债流动(元) | 882,000.00 | 936,000.00 | 987,000.00 | 963,000.00 | 952,000.00 | 568,000.00 | 622,000.00 | 750,000.00 |
| 应付账款及票据(元) | 6,270,000.00 | 5,030,000.00 | 4,685,000.00 | 5,252,000.00 | 8,608,000.00 | 9,807,000.00 | 8,684,000.00 | 8,957,000.00 |
| 递延收入流动(元) | 10,808,000.00 | 9,915,000.00 | 10,379,000.00 | 11,009,000.00 | 9,421,000.00 | 12,364,000.00 | 15,785,000.00 | 14,885,000.00 |
| 流动负债其他项目(元) | - | - | 1,000.00 | 1,000.00 | - | - | - | 1,000.00 |
| 流动负债合计(元) | 17,960,000.00 | 15,881,000.00 | 16,052,000.00 | 17,225,000.00 | 18,981,000.00 | 22,739,000.00 | 25,091,000.00 | 24,593,000.00 |
| 非流动负债： | ||||||||
| 融资租赁负债非流动(元) | 2,070,000.00 | 2,144,000.00 | 2,417,000.00 | 2,675,000.00 | 2,944,000.00 | 2,232,000.00 | - | - |
| 衍生工具负债非流动(元) | - | - | - | - | - | 4,000.00 | - | - |
| 递延收入非流动(元) | 18,693,000.00 | - | 21,688,000.00 | 24,017,000.00 | 27,725,000.00 | 26,544,000.00 | 25,774,000.00 | 30,821,000.00 |
| 递延所得税负债非流动(元) | 273,000.00 | 21,468,000.00 | 273,000.00 | 273,000.00 | 2,076,000.00 | 2,076,000.00 | 2,076,000.00 | 2,076,000.00 |
| 非流动负债其他项目(元) | - | - | - | - | 2,000.00 | - | 1,482,000.00 | 1,812,000.00 |
| 非流动负债合计(元) | 21,036,000.00 | 23,612,000.00 | 24,378,000.00 | 26,965,000.00 | 32,747,000.00 | 30,856,000.00 | 29,332,000.00 | 34,709,000.00 |
| 总负债(元) | 38,996,000.00 | 39,493,000.00 | 40,430,000.00 | 44,190,000.00 | 51,728,000.00 | 53,595,000.00 | 54,423,000.00 | 59,302,000.00 |
| 股东权益： | ||||||||
| 普通股(元) | 451,343,000.00 | 450,282,000.00 | 448,249,000.00 | 441,299,000.00 | 440,280,000.00 | 439,148,000.00 | 437,151,000.00 | 435,818,000.00 |
| 留存收益(元) | -384,856,000.00 | -380,081,000.00 | -372,971,000.00 | -367,742,000.00 | -363,370,000.00 | -357,016,000.00 | -350,947,000.00 | -344,184,000.00 |
| 累计其他全面收益(元) | -3,068,000.00 | -2,084,000.00 | -2,611,000.00 | -3,107,000.00 | -3,571,000.00 | -3,184,000.00 | -3,357,000.00 | -5,087,000.00 |
| 归属于母公司股东权益(元) | 63,419,000.00 | 68,117,000.00 | 72,667,000.00 | 70,450,000.00 | 73,339,000.00 | 78,948,000.00 | 82,847,000.00 | 86,547,000.00 |
| 少数股东权益(元) | -1,396,000.00 | -1,457,000.00 | -1,409,000.00 | -1,435,000.00 | -1,403,000.00 | -1,395,000.00 | -1,348,000.00 | -1,329,000.00 |
| 股东权益合计(元) | 62,023,000.00 | 66,660,000.00 | 71,258,000.00 | 69,015,000.00 | 71,936,000.00 | 77,553,000.00 | 81,499,000.00 | 85,218,000.00 |
| 负债及股东权益合计(元) | 101,019,000.00 | 106,153,000.00 | 111,688,000.00 | 113,205,000.00 | 123,664,000.00 | 131,148,000.00 | 135,922,000.00 | 144,520,000.00 |
| 公告日期 | 2024-03-07 | 2023-11-09 | 2023-08-10 | 2023-05-11 | 2023-03-09 | 2022-11-10 | 2022-08-11 | 2022-05-12 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||
| 核数师 |